共 98 条
[1]
Weinshenker BG(1989)The natural history of multiple sclerosis: a geographically based study. 2. Predictive value of the early clinical course Brain 112 1419-1428
[2]
Bass B(1997)Axonal damage in acute multiple sclerosis lesions Brain 120 393-399
[3]
Rice GP(1987)A double-blind controlled trial of high dose methylprednisolone in patients with multiple sclerosis: 1 clinical effects J Neurol Neurosurg Psychiatry 50 511-516
[4]
Ferguson B(2001)Glukokortikosteroid-Therapie bei Optikusneuritis und Multipler Sklerose. Evidenz aus klinischen Studien und praktische Empfehlungen Nervenarzt 72 577-589
[5]
Matyszak MK(2012)Oral versus intravenous steroids for treatment of relapses in multiple sclerosis Cochrane Database Syst Rev 12 1219-1220
[6]
Esiri MM(1993)Methylprednisolone in multiple sclerosis: a comparison of oral with intravenous therapy at equivalent high dose J Neurol Neurosurg Psychiatry 56 902-906
[7]
Perry VH(1997)Randomised trial of oral and intravenous methylprednisolone in acute relapses of multiple sclerosis Lancet 349 238-243
[8]
Milligan NM(1986)High-dose intravenous methylprednisolone in the treatment of multiple sclerosis: clinical-immunologic correlations Neurology 36 529-534
[9]
Newcombe R(2000)Corticosteroids or ACTH for acute exacerbations in multiple sclerosis Cochrane Database Syst Rev. 4 80-6
[10]
Compston DA(1998)Double-blind, randomized, placebo-controlled study of oral, high-dose methylprednisolone in attacks of MS Neurology 51 1-173